Media Room


Media Room

Welcome to the Schering-Plough Canada Media Room

The Media Room allows you to view and access the latest news about Schering-Plough Canada and our products. If you are looking for a particular topic, independent searches by therapeutic area can be performed within this section.

News Releases

All media news releases were issued in Canada and are intended as reference information for Canadians. The information in each media release was accurate at the time it was issued. Schering-Plough Canada assumes no responsibility for the updating of information to reflect subsequent developments.

Corporate News

November 04, 2009:
NEW MERCK BEGINS OPERATIONS WORLDWIDE
Merck & Co., Inc. (NYSE: MRK) today outlined its global strategy following the completion yesterday of Merck's merger with Schering-Plough Corporation. The new Merck, operating as MSD outside the United States and Canada, is a global health care leader aimed at providing innovative, distinctive products and services that save and improve lives, while satisfying customer needs and creating long-term shareholder value.
February 24, 2009:
New recycling program launched in Kirkland primary schools
Program provided by environmental partnership between Kirkland and Schering-Plough Canada
July 09, 2008:
Let's Make a Difference!
Schering-Plough Canada employees to volunteer time with West Island seniors

Latest Product News

June 03, 2009:
Video News Release on Psoriatic Arthritis
If you have itchy skin and aching joints, you might have a condition known as psoriatic arthritis. There are treatments available that are bringing relief to Canadians suffering from the little-known condition.
May 26, 2009:
Boceprevir eliminated Hep C virus in unprecedented number of patients
Patients that received a 48-week boceprevir regimen achieved a 75 per cent SVR rate, nearly twice the efficacy rate provided by current standard therapies.
May 21, 2009:
New ARB Shows Greater and Faster Blood Pressure Reduction for Patients With Hypertension
Olmetec® gives physicians new option to achieve earlier blood pressure reduction

News Feature

July 19, 2005:
First medicine approved for improvement in physical function in Ankylosing Spondylitis
Remicade® approved to treat Ankylosing Spondylitis, a chronic, debilitating disease of the spine



Site MapLinksContact UsFrançais
Search